Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer-Reference-Cited by-同舟云学术

Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer

Published:2019-03-03 Issue:8 Volume:49 Page:1005-1012
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bond Ashley¹^ORCID,Greenwood Rosemary²,Lewis Stephen³^ORCID,Corfe Bernard⁴⁵^ORCID,Sarkar Sanchoy¹,O'Toole Paul¹,Rooney Paul¹,Burkitt Michael¹⁶,Hold Georgina⁷^ORCID,Probert Chris¹⁶^ORCID

Affiliation:

1. Royal Liverpool and Broadgreen University Hospital Trust; Liverpool UK

2. Research Design Service; School of Social and Community Medicine; University of Bristol; Bristol UK

3. Derriford Hospital; Plymouth UK

4. Molecular Gastroenterology Research Group; Department of Oncology; University of Sheffield; Sheffield UK

5. Insigneo Institute for in silico Medicine; University of Sheffield; Sheffield UK

6. Gastroenterology Research Unit; Department of Molecular and Cellular Physiology; Institute of Translational Medicine; University of Liverpool; Liverpool UK

7. Microbiome Research Centre; St George & Sutherland Clinical School; UNSW; Sydney NSW Australia

Funder

Shire Innovation Fund

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15140/fullpdf

Reference38 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. The National Health Service Bowel Cancer Screening Program: the early years;Rees;Expert Rev Gastroenterol Hepatol,2013